ovarian cancer
Interviews and expert commentary tagged “ovarian cancer” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Tao Zhu MD; AACR 2026: Anti-Claudin 6 Antibody Drug Conjugate Benefits Patients with Advanced Platinum-Resistant Ovarian Cancer with Low Toxicity
Refractory Ovarian Cancer Yields to Claudin 6 Targeted Antibody Drug Conjugate
Victor Velculescu MD PhD: Ovarian Cancer Noninvasive Detection by Circulating DNA Fragmentome and Protein Biomarker AI Analysis
Victor E Velculescu MD PhD
BRCA1/2 Ovarian Cancer—Three Years Disease Free with First-Line Olaparib
BRCA1/2 Ovarian Cancer—Three Years Disease Free with First-Line Olaparib MUNICH—An “unprecedented improvement” in progression free survival (PFS) was observed in the randomized controlled
Niraparib Quadruples Progression Free Survival in Platinum-Sensitive Ovarian Cancer
COPENHAGEN, Denmark—Marked prolongation of progression free survival (PFS) in all groups of patients with platinum-sensitive recurrent ovarian cancer was reported at the European Society for Medical O
HAND2 gene: key to endometrial, ovarian cancer detection and treatment individualisation
LONDON— Researchers have shown that endometrial cancer — and hopefully ovarian cancer too — could potentially be detected much earlier than at present — or even prevented altogether — by looking for &